ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Gastroenterol Hepatol. 2024 May 6:502192. doi: 10.1016/j.gastrohep.2024.502192. Online ahead of print.
[Article in English, Spanish]

Abstract

Introduction: Ulcerative colitis (UC) and Crohn's disease (CD) are diseases that cause a significant impact on patients' quality of life.The aim of this study is to assess the impact of inflammatory bowel disease (IBD) on health-related quality of life (HRQoL).

Material and methods: Observational, descriptive, cross-sectional study, carried out at Torrecárdenas Hospital (Almería). Patients over 14 years of age diagnosed with CD or UC were included.For the assessment of HRQoL, the reduced 9-item IBDQ-9 questionnaire was used.

Results: 106 patients with a mean age of 44 years were included, with a female predominance. Forty-five percent of the patients in the sample had UC compared to 55% with CD. Of the patients, 69.8% were in clinical remission.The median questionnaire score was 60.8 points out of 100.Statistically significant differences were observed between sexes, with worse HRQoL for females. No differences were observed between patients with UC and CD. Differences were also detected between patients who underwent surgery and those who did not.A negative association was observed between the number of flares and the questionnaire score.

Conclusions: In our study population, there is an acceptable HRQoL, with no differences observed between CD and UC.Female sex, absence of clinical remission, number of previous outbreaks, and surgery have a negative association with HRQoL.

Keywords: Quality of life; abordaje biopsicosocial; biopsychosocial approach; calidad de vida; enfermedad inflamatoria intestinal; inflammatory bowel disease.